$ZVRA
Zevra Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$11.16
▲+1.45%+$0.160
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateZevra Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ZVRA up today? It is at $11.16 (+0.00%), and our scanner flagged it 49 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ZVRA spikes, and full due diligence on ZVRA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ZVRA 49 times in the last 30 days. Create a free account to track $ZVRA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ZVRA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ZVRA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystZEVRA THERAPEUTICS, INC.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Aug 17, 2026 · 52 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Thompson Rahsaan Officer | Sold (automatic/other) | -43K 0.07% of company | sold 53% | 38K | $475K at $11.13 | Aug 14, 26 |
Watton Corey Michael Director | Sold (automatic/other) | -12K 0.02% of company | sold 87% | 2K | $138K at $11.25 | Aug 10, 26 |
Watton Corey Michael Director | Other | 12K 0.02% of company | added 100% | 14K | $61K at $4.97 | Aug 10, 26 |
Thompson Rahsaan Officer | Sold (automatic/other) | -35K 0.06% of company | sold 30% | 80K | $438K at $12.68 | Jun 22, 26 |
Thompson Rahsaan Officer | Other | 67K 0.1% of company | added 100% | 115K | n/a | Jun 21, 26 |
Thompson Rahsaan Officer | Sold (automatic/other) | -2K | sold 3.6% | 48K | $20K at $11.30 | May 11, 26 |
Bode John B Director | Other | 78K 0.1% of company | added 100% | 123K | $383K at $4.89 | Mar 24, 26 |
Mcfarlane Neil F. Officer | Sold (automatic/other) | -15K 0.02% of company | sold 3.6% | 387K | $125K at $8.56 | Feb 9, 26 |
Mcfarlane Neil F. Officer | Other | 38K 0.06% of company | added 10% | 402K | n/a | Feb 7, 26 |
Schafer Joshua Officer | Sold (automatic/other) | -11K 0.02% of company | sold 14% | 62K | $96K at $9.19 | Feb 3, 26 |
Sangiovanni Timothy J. Officer | Sold (automatic/other) | -3K | sold 9.2% | 30K | $28K at $9.18 | Feb 3, 26 |
Mcfarlane Neil F. Officer | Sold (automatic/other) | -91K 0.2% of company | sold 20% | 364K | $854K at $9.38 | Feb 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ZVRA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ZVRA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ZVRA last traded at $11.16, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Zevra Therapeutics, Inc. Common Stock (ZVRA) is next expected to report earnings on Wednesday, November 4, 2026, about 26 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ZVRA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ZVRA 49 times in the last 30 days.
ZVRA (Zevra Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $653M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ZVRA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ZVRA discussion
Sign in to ask a question or join the discussion.